Related references
Note: Only part of the references are listed.
Article
Gastroenterology & Hepatology
Lenvatinib as First-line Treatment of Hepatocellular Carcinoma in Patients with Impaired Liver Function in Advanced Liver Cirrhosis: Real World Data and Experience of a Tertiary Hepatobiliary Center
Lidia-Sabina Cosma et al.
Summary: Lenvatinib shows similar tolerability and toxicity in patients with hepatocellular cancer, with better survival benefits observed in patients with Child-Pugh class A and B liver cirrhosis.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2021)
Article
Oncology
Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study
Omar Abdel-Rahman
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Article
Gastroenterology & Hepatology
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2017)
Share Paper
